甲状腺髓样癌：靶向治疗及未来方向。
Medullary thyroid carcinoma: targeted therapies and future directions.
机构信息
Endocrine Surgery Research Laboratory, Department of Surgery, University of Wisconsin, H4/722 Clinical Science Center, 600 Highland Avenue, Madison, WI 53792, USA.
出版信息
J Oncol. 2009;2009:183031. doi: 10.1155/2009/183031. Epub 2009 Dec 24.
Abstract
Medullary thyroid cancer (MTC) is a rare neuroendocrine neoplasm that accounts for approximately 5% of all thyroid malignancies. The natural history of MTC is characterized by early lymph node and distant metastases, making complete surgical cure often impossible. Conventional chemotherapy and external beam radiation have been largely ineffective in altering the natural history of MTC. Therefore, there is a great need to develop novel therapeutic strategies to affect symptom control and reduce tumor burden in patients with widely disseminated disease. Here, we review several pathways which have been shown to be vital in MTC tumorigenesis and focus on the pathways of interest for which targeted drug therapies are currently being developed.
摘要
甲状腺髓样癌（MTC）是一种罕见的神经内分泌肿瘤，约占所有甲状腺恶性肿瘤的 5%。MTC 的自然病程以早期淋巴结和远处转移为特征，因此通常无法完全手术治愈。传统的化疗和外照射在改变 MTC 的自然病程方面效果甚微。因此，迫切需要开发新的治疗策略，以控制症状并减轻广泛播散性疾病患者的肿瘤负担。在这里，我们回顾了一些已被证明对 MTC 肿瘤发生至关重要的途径，并重点介绍了目前正在开发针对这些途径的靶向药物治疗的途径。
相似文献
1
Medullary thyroid carcinoma: targeted therapies and future directions.
J Oncol. 2009;2009:183031. doi: 10.1155/2009/183031. Epub 2009 Dec 24.
2
Medullary thyroid carcinoma: management of lymph node metastases.
J Natl Compr Canc Netw. 2010 May;8(5):549-56. doi: 10.6004/jnccn.2010.0042.
3
Breach of the thyroid capsule and lymph node capsule in node-positive papillary and medullary thyroid cancer: Different biology.
Eur J Surg Oncol. 2015 Jun;41(6):766-72. doi: 10.1016/j.ejso.2014.10.049. Epub 2014 Oct 27.
4
Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
G Chir. 2012 Nov-Dec;33(11-12):395-9.
5
Long-Term Follow-up in Medullary Thyroid Carcinoma.
Recent Results Cancer Res. 2015;204:207-25. doi: 10.1007/978-3-319-22542-5_10.
6
Static Prognostic Factors and Appropriate Surgical Designs for Patients with Medullary Thyroid Carcinoma: The Second Report from a Single-Institution Study in Japan.
World J Surg. 2018 Dec;42(12):3954-3966. doi: 10.1007/s00268-018-4738-z.
7
Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
J Clin Endocrinol Metab. 2003 May;88(5):2070-5. doi: 10.1210/jc.2002-021713.
8
Histone Deacetylase Inhibitors: A Novel Therapeutic Weapon Against Medullary Thyroid Cancer?
Anticancer Res. 2016 Oct;36(10):5019-5024. doi: 10.21873/anticanres.11070.
9
Medullary Thyroid Cancer - Feature Review and Update on Systemic Treatment.
Acta Clin Croat. 2020 Jun;59(Suppl 1):50-59. doi: 10.20471/acc.2020.59.s1.06.
10
Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
J Laryngol Otol. 2016 May;130(S2):S150-S160. doi: 10.1017/S0022215116000578.
引用本文的文献
1
A novel CCK2/gastrin receptor-localizing radiolabeled peptide probe for personalized diagnosis and therapy of patients with progressive or metastatic medullary thyroid carcinoma: a multicenter phase I GRAN-T-MTC study.
Pol Arch Intern Med. 2018 Dec 21;128(12):791-795. doi: 10.20452/pamw.4387. Epub 2018 Dec 5.
2
Thailandepsin A-loaded and octreotide-functionalized unimolecular micelles for targeted neuroendocrine cancer therapy.
Biomaterials. 2016 Jun;91:1-10. doi: 10.1016/j.biomaterials.2016.03.010. Epub 2016 Mar 8.
3
Growth arrest signaling of the Raf/MEK/ERK pathway in cancer.
Front Biol (Beijing). 2014 Feb;9(2):95-103. doi: 10.1007/s11515-014-1299-x.
4
Cabozantinib for progressive metastatic medullary thyroid cancer: a review.
Ther Clin Risk Manag. 2014 May 28;10:395-404. doi: 10.2147/TCRM.S46041. eCollection 2014.
5
The Role of STAT3 in Thyroid Cancer.
Cancers (Basel). 2014 Mar 6;6(1):526-44. doi: 10.3390/cancers6010526.
6
New developments in the diagnosis and treatment of thyroid cancer.
CA Cancer J Clin. 2013 Nov-Dec;63(6):374-94. doi: 10.3322/caac.21195. Epub 2013 Jun 24.
7
Glucagon-Like Peptide-1 Receptor Imaging with [Lys (40) (Ahx-HYNIC- (99 m) Tc/EDDA)NH 2 ]-Exendin-4 for the Diagnosis of Recurrence or Dissemination of Medullary Thyroid Cancer: A Preliminary Report.
Int J Endocrinol. 2013;2013:384508. doi: 10.1155/2013/384508. Epub 2013 Mar 31.
本文引用的文献
1
Regulation of cell-cell contact molecules and the metastatic phenotype of medullary thyroid carcinoma by the Raf-1/MEK/ERK pathway.
Surgery. 2008 Dec;144(6):920-4; discussion 924-5. doi: 10.1016/j.surg.2008.07.020.
2
Proteomics study of medullary thyroid carcinomas expressing RET germ-line mutations: identification of new signaling elements.
Mol Carcinog. 2009 Mar;48(3):220-231. doi: 10.1002/mc.20474.
3
Motesanib diphosphate in progressive differentiated thyroid cancer.
N Engl J Med. 2008 Jul 3;359(1):31-42. doi: 10.1056/NEJMoa075853.
4
Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study.
J Clin Oncol. 2008 Oct 10;26(29):4708-13. doi: 10.1200/JCO.2007.15.9566. Epub 2008 Jun 9.
5
Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells.
Ann Surg. 2008 Jun;247(6):1036-40. doi: 10.1097/SLA.0b013e3181758d0e.
6
Novel targets for the treatment and palliation of gastrointestinal neuroendocrine tumors.
Curr Opin Investig Drugs. 2008 Jun;9(6):576-82.
7
Current management of medullary thyroid cancer.
Oncologist. 2008 May;13(5):539-47. doi: 10.1634/theoncologist.2007-0239.
8
Suberoyl bis-hydroxamic acid activates Notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells.
Oncologist. 2008 Feb;13(2):98-104. doi: 10.1634/theoncologist.2007-0190.
9
Neuroendocrine tumor cell growth inhibition by ZM336372 through alterations in multiple signaling pathways.
Surgery. 2007 Dec;142(6):959-64; discussion 959-64. doi: 10.1016/j.surg.2007.09.020.
10
Fine-needle aspiration may miss a third of all malignancy in palpable thyroid nodules: a comprehensive literature review.
Ann Surg. 2007 Nov;246(5):714-20. doi: 10.1097/SLA.0b013e3180f61adc.
Zotero 插件